IVC Filters Show Mixed Outcomes in APE

Evidence synthesis highlights reduced embolism risk but persistent safety concerns and no survival benefit.

1

IVC filters may reduce acute pulmonary embolism risk but do not improve mortality and can increase deep vein thrombosis rates in venous thromboembolism patients.
2

Randomized trials show IVC filters lower PE events but have no survival benefit, with increased DVT rates compared to anticoagulation alone.
3

Potential benefits of IVC filters may be seen in specific high-risk groups, such as patients with recurrent APE or hemodynamically unstable conditions.
4

Complications from IVC filters are common, including access site bleeding and long-term DVT, with significant rates of recurrent DVT reported.
5

Current guidelines recommend selective IVC filter use in patients with contraindications to anticoagulation, emphasizing planned retrieval after therapy.

1